Canadian Cancer Trials Group Bulletins


Recent Publications

Canadian Cancer Trials Group BR.14 - A Phase III Study of Gemcitabine Plus Vinorelbine Compared to Standard Cisplatin Containing Chemotherapy For Stage IIIb or IV Non-Small Cell Lung Cancer

Reaume MN, Leighl NB, Mittmann N, Coyle D, Hirsh V, Seymour L, Tu D, Shepherd FA, Graham B, Gridelli C, Perrone F, Di Maio M, Bradbury PA, Evans WK. Economic analysis of a randomized phase III trial of gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer (Italian GEMVIN3/Canadian Cancer Trials Group BR14 trial) (ONLINE). Lung Cancer 2013.


Canadian Cancer Trials Group IND.160 - A Phase II Study Of CCI-779 in Patients with Metastatic and/or Locally Advanced Recurrent Endometrial Cancer

Goodwin RA, Jamal R, Tu D, Walsh W, Dancey J, Oza AM, Elit L, Eisenhauer EA. Clinical and toxicity predictors of response and progression to temsirolimus in women with recurrent or metastatic endometrial cancer (ONLINE). Gynecol Oncol 2013.